| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.6 |